LCSSX | RRMGX | LCSSX / RRMGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 12 years | 22 years | - |
Gain YTD | 13.975 | 8.605 | 162% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.33B | 31.4B | 11% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 28.78 | 13.62 | 211% |
Returns for 3 years | -7.75 | -16.28 | 48% |
Returns for 5 years | 87.94 | 9.23 | 953% |
Returns for 10 years | 251.86 | 33.74 | 747% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NEMCX | 19.65 | -0.03 | -0.15% |
Neuberger Berman Emerg Mkts Eq C | |||
LMPPX | 36.77 | -0.07 | -0.19% |
ClearBridge Appreciation R | |||
HIOIX | 11.75 | -0.04 | -0.34% |
Fintrust Income and Opportunity Instl | |||
HRMDX | 15.00 | -0.09 | -0.60% |
Heartland Mid Cap Value Investor | |||
PHSYX | 75.07 | -0.65 | -0.86% |
Putnam Global Health Care Y |